Qube Research & Technologies (QRT)
CUE icon

Qube Research & Technologies (QRT)’s Cue Biopharma CUE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-822
Closed -$18.7K – 3515
2024
Q3 		$18.7K Sell
822
-1,852
-69% -$40.1K ﹤0.01% 2980
2024
Q2 		$99.5K Buy
+2,674
New +$132K ﹤0.01% 2607
2023
Q1 		– Sell
-960
Closed -$82.1K – 2611
2022
Q4 		$82.1K Buy
960
+112
+13% +$10.2K ﹤0.01% 2044
2022
Q3 		$57K Sell
848
-187
-18% -$16.1K ﹤0.01% 2107
2022
Q2 		$77K Buy
+1,035
New +$121K ﹤0.01% 2025
2020
Q3 		– Sell
-445
Closed -$327K – 1747
2020
Q2 		$327K Buy
+445
New +$322K ﹤0.01% 1259

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CUE Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of Cue Biopharma (CUE) in Q4 2024, closing a stake of 822 shares — an estimated $18.7K sold.

Qube Research & Technologies (QRT) first reported a position in CUE in Q2 2020 and held it in 6 quarters. The position peaked at $327K in Q2 2020. 54 funds tracked by Wall St. Rank hold CUE as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining Cue Biopharma position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 822 Cue Biopharma shares in Q4 2024, an estimated $18.7K.
  • Qube Research & Technologies (QRT) first reported a position in Cue Biopharma in Q2 2020 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Cue Biopharma position peaked at $327K in Q2 2020.
  • 54 funds tracked by Wall St. Rank held Cue Biopharma as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.